Form 4: United Therapeutics Director Judy D. Olian Executes Stock Option and Sells Shares

Director Judy D. Olian exercised stock options and sold shares of United Therapeutics Corp (UTHR) on March 12, 2024.

Summary

• On March 12, 2024, Judy D. Olian, a director of United Therapeutics Corp (UTHR), exercised stock options for 5,000 shares at a price of $175.43 per share.
• Following the exercise of options, Olian sold a total of 5,000 shares in multiple transactions.
• The sales were executed at weighted average prices of $247.1452 for 750 shares, $248.0278 for 2,500 shares, and $248.9017 for 1,750 shares.
• After these transactions, Olian directly owns 7,305 shares of United Therapeutics Corp.
• Olian also holds 10,000 stock options.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors. It's common for executives to exercise stock options and sell shares for personal financial management.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
• Comparable companies like Gilead Sciences (GILD) and Amgen (AMGN) also have similar filings when their executives trade company stock.
• The reported transactions are within the typical range observed for executive stock option exercises and sales.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates